SCHEMBL19861159

SCHEMBL19861159

CCCCCCC(C)(CCCC)CC(=O)OCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
HTT P42858 1/20 0.41
PAM P19021 2/20 0.41
NAAA Q02083 1/20 0.40
DGKA P23743 1/20 0.40
GAA P10253 2/20 0.40
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
THRB P10828 1/20 0.39
PKM P14618 1/20 0.39
CES2 O00748 1/20 0.38
LPAR1 Q92633 1/20 0.38
LPAR3 Q9UBY5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27574672 0.96 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19645194 0.94 GAA (0.43) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19645199 0.91 MEN1 (0.47) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL28617178 0.91 GAA (0.43) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL12855109 0.87 GAA (0.40) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL20076183 0.84 MAPT (0.47) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL20457453 0.84 FFAR1 (0.48) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19176823 0.84 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL21654072 0.84 MEN1 (0.49) MEN1MAPTKMT2AATML3MBTL1
SCHEMBL19861329 0.84 FFAR1 (0.48) MEN1MAPTKMT2AATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11040028-B2 Penicinotam derivative, preparation method and use thereof OCEAN UNIVERSITY OF CHINA (CN) 2021-06-22 US disclosed
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 US disclosed
US-9890198-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2018-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 MEN1 523/4885MAPT 1415/4885KMT2A 4492/4885
US-11040028-B2 Penicinotam derivative, preparation method and use thereof TPMT, MAPT, TLR4 MEN1 1591/4885MAPT 2/4885KMT2A 3442/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 MEN1 786/4885MAPT 1874/4885KMT2A 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.